Literature DB >> 2992211

Tangier disease. A case with sensorimotor distal polyneuropathy and lipid accumulation in striated muscle and vasa nervorum.

A Marbini, F Gemignani, G Ferrarini, S Maccari, B Lucci, M M Bragaglia, C Plancher, C Vergani.   

Abstract

A 65-year-old man with Tangier disease (analphalipoproteinemia) had had a progressive sensorimotor distal neuropathy with sensory ataxia for 1 year. Muscle biopsy demonstrated excess lipid vacuoles on histochemical and electron-microscopic techniques. Sural nerve biopsy showed a marked loss of large fibers and an increase in small myelinated fibers, with presence of remyelinating fibers and clusters of regeneration; a few aspects of active demyelination and some onion-like formations were also present. Lipid accumulation chiefly affected the Schwann cells of unmyelinated fibers and, to a lesser degree, of myelinated fibers, endoneurial fibroblast, and vasa nervorum. Teased fibers showed prevalent aspects of de-/remyelination and, often in association, marked myelin wrinkling suggesting axonal atrophy. This Tangier patient differs from known cases for the presence of a distal symmetrical sensorimotor polyneuropathy (not previously reported in Tangier disease) and because of the morphological findings of de-/remyelination coexisting with aspects of axonal atrophy and previous degeneration, and of lipid accumulation within striated muscle and vasa nervorum. This latter finding contrasts with the assumption that in Tangier disease vessel walls are not a site of lipid storage: probably the vasa nervorum are different, in this respect, from other vessels, because of the intense lipid metabolism of the nervous tissue. Thus we suggest that involvement of vasa nervorum in Tangier disease may be more important than previously suspected, possibly playing a role in the causation of neuropathy.

Entities:  

Mesh:

Year:  1985        PMID: 2992211     DOI: 10.1007/bf00688132

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  20 in total

1.  Tangier disease (alpha-lipoprotein deficiency).

Authors:  J G Brook; R S Lees; J H Yules; B Cusack
Journal:  JAMA       Date:  1977-07-25       Impact factor: 56.272

2.  The polyneuropathy of chronic renal failure.

Authors:  P K Thomas; K Hollinrake; R G Lascelles; D J O'Sullivan; R A Baillod; J F Moorhead; J C Mackenzie
Journal:  Brain       Date:  1971       Impact factor: 13.501

3.  Familial alpha-lipoprotein deficiency (Tangier disease) with neurological abnormalities.

Authors:  R S Kocen; J K Lloyd; P T Lascelles; A S Fosbrooke; D Willims
Journal:  Lancet       Date:  1967-06-24       Impact factor: 79.321

4.  Tangier disease (familial high density lipoprotein deficiency). Clinical and genetic features in two adults.

Authors:  H N Hoffman; D S Fredrickson
Journal:  Am J Med       Date:  1965-10       Impact factor: 4.965

5.  Pathological study of the sural nerve in Fabry's disease.

Authors:  F Gemignani; A Marbini; M M Bragaglia; E Govoni
Journal:  Eur Neurol       Date:  1984       Impact factor: 1.710

6.  Hypertrophic neuropathy in Sjögren;s syndrome.

Authors:  A Marbini; F Gemignani; P Manganelli; E Govoni; M M Bragaglia; U Ambanelli
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

7.  Involvement of peripheral nerve and muscle in Fabry's disease. Histologic, ultrastructural, and morphometric studies.

Authors:  A A Sima; D M Robertson
Journal:  Arch Neurol       Date:  1978-05

8.  Endoneurial ATPase activity in Tangier disease and other peripheral neuropathies.

Authors:  W H Sutherland; M Pollock
Journal:  Muscle Nerve       Date:  1984 Jul-Aug       Impact factor: 3.217

9.  Adult-onset of Tangier disease: 1. Morphometric and pathologic studies suggesting delayed degradation of neutral lipids after fiber degeneration.

Authors:  P J Dyck; R D Ellefson; J K Yao; P N Herbert
Journal:  J Neuropathol Exp Neurol       Date:  1978 Mar-Apr       Impact factor: 3.685

10.  Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).

Authors:  E J Schaefer; L L Kay; L A Zech; H B Brewer
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

View more
  5 in total

1.  Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.

Authors:  Madhu Nagappa; Arun B Taly; Anita Mahadevan; M Pooja; P S Bindu; Y T Chickabasaviah; N Gayathri; Sanjib Sinha
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

2.  Peroneal muscular atrophy with hereditary spastic paraparesis (HMSN V) is pathologically heterogeneous. Report of nerve biopsy in four cases and review of the literature.

Authors:  F Gemignani; D Guidetti; P Bizzi; P Preda; G Cenacchi; A Marbini
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Acute presentation of Tangier polyneuropathy: a clinical and morphological study.

Authors:  R Fazio; R Nemni; A Quattrini; G Ruotolo; S Iannaccone; D Mamoli; M Lodi; N Canal
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  An uncommon cause of bifacial weakness and non-length-dependent demyelinating neuropathy.

Authors:  Madhu Nagappa; Arun B Taly; Anita Mahadevan; Mailankody Pooja; Parayil Sankaran Bindu; Yasha T Chickabasaviah; Narayanappa Gayathri; Sanjib Sinha
Journal:  Ann Indian Acad Neurol       Date:  2015 Oct-Dec       Impact factor: 1.383

5.  A Novel Mutation in ABCA1 Gene Causing Tangier Disease in an Italian Family with Uncommon Neurological Presentation.

Authors:  Marco Ceccanti; Chiara Cambieri; Vittorio Frasca; Emanuela Onesti; Antonella Biasiotta; Carla Giordano; Sabina M Bruno; Giancarlo Testino; Marco Lucarelli; Marcello Arca; Maurizio Inghilleri
Journal:  Front Neurol       Date:  2016-11-02       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.